231 related articles for article (PubMed ID: 8467455)
1. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.
Piver MS; Jishi MF; Tsukada Y; Nava G
Cancer; 1993 May; 71(9):2751-5. PubMed ID: 8467455
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. Papillary peritoneal carcinomatosis after prophylactic oophorectomy.
Kemp GM; Hsiu JG; Andrews MC
Gynecol Oncol; 1992 Dec; 47(3):395-7. PubMed ID: 1473756
[TBL] [Abstract][Full Text] [Related]
4. Serous carcinoma of the peritoneum after oophorectomy.
Weber AM; Hewett WJ; Gajewski WH; Curry SL
Obstet Gynecol; 1992 Sep; 80(3 Pt 2):558-60. PubMed ID: 1495737
[TBL] [Abstract][Full Text] [Related]
5. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Rebbeck TR; Lynch HT; Neuhausen SL; Narod SA; Van't Veer L; Garber JE; Evans G; Isaacs C; Daly MB; Matloff E; Olopade OI; Weber BL;
N Engl J Med; 2002 May; 346(21):1616-22. PubMed ID: 12023993
[TBL] [Abstract][Full Text] [Related]
7. Familial peritoneal ovarian carcinomatosis: a new clinical entity?
Lynch HT; Bewtra C; Lynch JF
Med Hypotheses; 1986 Oct; 21(2):171-7. PubMed ID: 3641031
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.
Olivier RI; van Beurden M; Lubsen MA; Rookus MA; Mooij TM; van de Vijver MJ; van't Veer LJ
Br J Cancer; 2004 Apr; 90(8):1492-7. PubMed ID: 15083174
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.
Casey MJ; Bewtra C
Fam Cancer; 2004; 3(3-4):265-81. PubMed ID: 15516851
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome.
Chen KT; Schooley JL; Flam MS
Obstet Gynecol; 1985 Sep; 66(3 Suppl):93S-94S. PubMed ID: 4022524
[TBL] [Abstract][Full Text] [Related]
11. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
12. Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.
Rutter JL; Wacholder S; Chetrit A; Lubin F; Menczer J; Ebbers S; Tucker MA; Struewing JP; Hartge P
J Natl Cancer Inst; 2003 Jul; 95(14):1072-8. PubMed ID: 12865453
[TBL] [Abstract][Full Text] [Related]
13. Role of prophylactic hysterectomy in patients at high risk for hereditary cancers.
Villella JA; Parmar M; Donohue K; Fahey C; Piver MS; Rodabaugh K
Gynecol Oncol; 2006 Sep; 102(3):475-9. PubMed ID: 16473397
[TBL] [Abstract][Full Text] [Related]
14. Familial ovarian cancer. A report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981-1991.
Piver MS; Baker TR; Jishi MF; Sandecki AM; Tsukada Y; Natarajan N; Mettlin CJ; Blake CA
Cancer; 1993 Jan; 71(2 Suppl):582-8. PubMed ID: 8420680
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers.
Menkiszak J; Chudecka-Głaz A; Gronwald J; Cymbaluk-Płoska A; Celewicz A; Świniarska M; Wężowska M; Bedner R; Zielińska D; Tarnowska P; Jakubowicz J; Kojs Z
J Ovarian Res; 2016 Feb; 9():11. PubMed ID: 26928677
[TBL] [Abstract][Full Text] [Related]
16. Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.
Werness BA; Ramus SJ; DiCioccio RA; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; Tsukada Y; Harrington P; Gayther SA; Ponder BA; Piver MS
Int J Gynecol Pathol; 2004 Jan; 23(1):29-34. PubMed ID: 14668547
[TBL] [Abstract][Full Text] [Related]
17. Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case.
Kaplan EJ; Caputo TA; Shen PU; Sassoon RI; Soslow RA
Gynecol Oncol; 1998 Aug; 70(2):289-94. PubMed ID: 9740708
[TBL] [Abstract][Full Text] [Related]
18. A diagnostic dilemma following risk-reducing surgery for BRCA1 mutation - a case report of primary papillary serous carcinoma presenting as sigmoid cancer.
Chand M; Moore PJ; Clarke AD; Nash GF; Hickisk T
World J Surg Oncol; 2007 Sep; 5():102. PubMed ID: 17850658
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Schmeler KM; Lynch HT; Chen LM; Munsell MF; Soliman PT; Clark MB; Daniels MS; White KG; Boyd-Rogers SG; Conrad PG; Yang KY; Rubin MM; Sun CC; Slomovitz BM; Gershenson DM; Lu KH
N Engl J Med; 2006 Jan; 354(3):261-9. PubMed ID: 16421367
[TBL] [Abstract][Full Text] [Related]
20. Anxiety/uncertainty reduction as a motivation for interest in prophylactic oophorectomy in women with a family history of ovarian cancer.
Hurley KE; Miller SM; Costalas JW; Gillespie D; Daly MB
J Womens Health Gend Based Med; 2001 Mar; 10(2):189-99. PubMed ID: 11268302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
